Navigation Links
New lung cancer drug shows dramatic results for shrinking tumors
Date:6/22/2010

Media Contact: Karen Shea 61

Patients with a specific kind of lung cancer may benefit from a Phase III clinical trial offered by the Moores UCSD Cancer Center. The new drug, crizotinib, under development by Pfizer, showed dramatic results in reducing lung cancer tumors in some patients during Phase I and II clinical trials.

"The results of the first two trials have been very encouraging," said Lyudmila Bazhenova, MD, assistant clinical professor at UC San Diego School of Medicine and a member of the Moores UCSD Cancer Center. "The Phase III clinical trials will be critical in determining if this drug goes to market."

According to a preliminary study presented at the 2010 meeting of the American Society of Clinical Oncology, Phase I/II clinical trials demonstrated that 57% of patients had their tumors reduced and at eight weeks of the treatment, 87% showed disease stabilization.

In some patients with non-small cell lung cancer (NSCLC), the anaplastic lymphoma kinase (ALK) gene may move and fuse with another gene, EML4. The resultant fusion produces an enzyme that promotes lung cancer cell growth. This fusion happens in approximately four percent of NSCLC patients. The chances of a patient having the fusion gene increases if they have the adenocarcinoma subtype of lung cancer, or are non-smokers or former light smokers, among other characteristics. Those patients have an approximate 20% chance of having this mutation. Crizotinib inhibits the enzyme, allowing the cancer cells to die off.

The Phase III clinical trial will compare crizotinib with standard-of-care chemotherapy in the treatment of ALK-positive recurrent NSCLC. Through a randomized selection process, patients will either be treated with chemotherapy or crizotinib. If the patients who are given the chemotherapy do not respond to treatment, they will be given crizotinib at the end of the trial.


'/>"/>

Contact: Karen Shea
kshea@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Page: 1

Related medicine news :

1. Scripps Announces Plans for Region's First Proton Therapy Center; $185 Million Facility to Offer Advanced Care to Cancer Patients
2. Chlordecone exposure and risk of prostate cancer
3. Kids Into Safe Skin (K.I.S.S) Officially Launches Today with a Mission to Create Awareness About Skin Cancer Detection and Prevention
4. Cancer and Multiple Sclerosis Survivor Martin Smith's 3,000-mile Bicycle Ride Benefits Cancer Research
5. Cancers of sweat glands, other skin-related structures may be increasing in United States
6. New drugs to relieve cancer pain
7. Hematology-Oncology Associates of Northern New Jersey (HOANNJ) Joins Effort to Improve Cancer Care with Via Oncology™ Pathways
8. Coffee Might Guard Against Head, Neck Cancers
9. Surveillance may be suitable treatment option for patients with low-risk prostate cancer
10. Watchful Waiting Often Best Strategy for Slow-Moving Prostate Cancer
11. Second Ohio State cancer drug begins clinical trials testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... August 29, 2014 Recently, iFitDress.com, the ... new selection of chic bridesmaid dresses . Included ... items. In addition, all of them are provided at ... , iFitDress.com insists on offering fast and reliable delivery ... what they order in a short time. As is ...
(Date:8/28/2014)... August 28, 2014 Blood's Thicker Than Water ... money and family ties in the heart of the city. ... – a story about how disrespect caused two families to ... many streets. , The Yayo Boyz and the M.O.B. Boyz ... speechless and local onlookers in a silent terror. "Guerrilla," AKA ...
(Date:8/28/2014)... FL (PRWEB) August 28, 2014 Millennium ... use affecting users in the workplace. A recent ... Dependence (NCADD) states that drug abuse is costing ... who use or are addicted to drugs affect their ... activities carry over into the workplace, causing expensive problems ...
(Date:8/28/2014)... government plans its exit strategy from the war, now may ... providing health care to veterans, says a Perspective piece in ... simply go on doing more of the same is to ... cost and population structure pose in the longer run," said ... Clinical Practice, and David Auerbach, from the RAND Corporation, in ...
(Date:8/28/2014)... 2014 The Governor of Yucatán, Rolando ... at a press conference; this event is organized by ... of Economy through the National Microenterprise Financing Program ( ... to the 5th at the Convention Center Yucatan Siglo ... a great responsibility for Yucatan to host the 17th ...
Breaking Medicine News(10 mins):Health News:New Selection of Chic Bridesmaid Dresses Available at iFitDress.com 2Health News:Raymond E. Blake Releases Blood's Thicker Than Water, Based on a True Story 2Health News:Drug Use Causes Problems in the Workplace 2Health News:A VA exit strategy 2Health News:Governor of the State of Yucatan presents the 17th Microcredit Summit 2Health News:Governor of the State of Yucatan presents the 17th Microcredit Summit 3
... of the daughters of women who had been given DES, ... that exposure to the drug while in the womb (in ... risk of certain cancers and pre-cancerous conditions. The results of ... (NCI), part of the National Institutes of Health, and collaborators ...
... HealthDay Reporter , WEDNESDAY, Oct. 5 (HealthDay News) -- A ... to reduce relapse rates and disability progression, according to the ... drug, teriflunomide, is one of the few oral drugs that ... a good choice for many MS patients, researchers said. ...
... of young people with melanoma, a deadly form of skin ... of invasive disease than adults. The study, published online ... to be the first to compare disease spread in children ... between childhood and adult melanoma, the researchers say. ...
... Beach, Fla. The prognosis for patients with stage ... is poor, with only about 15 percent of patients ... new treatment strategies are being intensely studied, timely assessment ... today, Mitchell Machtay, MD, principal investigator of the ACRIN ...
... 5, 2011)Approximately 10-20 percent of prostate cancer patients have a ... factors that are used to evaluate the extent and aggressiveness ... the Prostate Specific Antigen Level (PSA), Gleason score (GS) ... However, men with a family history of prostate cancer ...
... 5, 2011 The Merck Childhood Asthma Network, ... in funding to implement the Community Healthcare for ... in five non-profit, Federally Qualified Health Centers. This ... to demonstrate how asthma management tools proven effective ...
Cached Medicine News:Health News:Women exposed to diethylstilbestrol in the womb face increased cancer risk 2Health News:Women exposed to diethylstilbestrol in the womb face increased cancer risk 3Health News:Experimental MS Drug Shows Promise 2Health News:Experimental MS Drug Shows Promise 3Health News:Invasive melanoma may be more likely in children than adults 2Health News:FDG-PET appears promising for predicting prognosis of patients with inoperable NSCLC 2Health News:More aggressive treatment not necessary for men with a family history of prostate cancer 2Health News:Childhood asthma non-profit invests millions in health centers to help children better manage asthma 2Health News:Childhood asthma non-profit invests millions in health centers to help children better manage asthma 3
(Date:8/28/2014)... , Aug. 28, 2014 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html ... discover technological and commercial prospects What does ... market? Visiongain,s brand new report shows you ...
(Date:8/28/2014)... 2014 Pharmatech initiated enrollment for its ... game-changing method for matching cancer patients to cancer ... target specific cancers, disease staging, and genetic mutations ... cancer, in the first place. The challenge that ... not be well known to the patient or ...
(Date:8/28/2014)... , Aug. 28, 2014 Tianyin Pharmaceutical ... a pharmaceutical company that specializes in patented biopharmaceutical, ... active pharmaceutical ingredients (API) today updates the timeline ... Facility (QLF). The Company is ... dataset for China Food & Drug Administration,s (CFDA) ...
Breaking Medicine Technology:Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18Enrollment in Pharmatech's Revolutionary AccessPPM Program Launches 2TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2
Inquire...
300 L, Racked, Filtered, Pre-sterilized, 96 tips/rack Recommended for 250 and 300 L pipettes....
... Aerosol barrier tips eliminate false signals ... designed and tested, Promega Barrier Tips ... with amplified nucleic acids (PCR(a)), radioactive ... forensic and serological specimens. , ,Promega ...
Diamond Filter Tips play a critical role in preventing aerosol-borne contamination. Also available sterilized (no need to autoclave) and certified free of detectable RNase, DNase, DNA, RNA, and prote...
Medicine Products: